Efficacy and preliminary safety assessment of EXG001-307 AAV gene therapy for spinal muscular atrophy

ABSTRACT:

SUBMITTER: Song C 

PROVIDER: S-EPMC12127541 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature